Pediatric Urology
Principal Investigator: Dr. Sumit Dave
Co-Investigator: Dr. Peter Wang
Study Coordinator: Jacob Davidson 519.685.8500 ext 53298
BOTOX® in the treatment of urinary incontinence due to overactive bladder in patients 12-17 years of age
Principal Investigator: Dr. Peter Wang
Co-Investigator: Dr. Sumit Dave
Study Coordinator: Jacob Davidson 519.685.8500 ext 53298
A phase 3, double-blind, randomized, multicenter, parallel group, placebo-controlled, sequential dose titration study to evaluate efficacy, safety and pharmacokinetics of Mirabegron in pediatric subjects from 5 to <18 years of age with overactive bladder
